Research type:
|
Secondary Research (e.g. systematic review) |
Title (lead author) etc:
|
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy (Williams) 222 pages, Volume 10, number 34 |
DOI
|
10.3310/hta10340 |
View/print executive summary
View/print abstract
View full text in pdf format (1019 KB)
 This title is available on our CD-ROM of the journal.
 Order a CD-ROM - free of charge worldwide.
Go to our correspondence page to comment on this publication
|
Headline: |
Model developed to help determine which patients with breast cancer may benefit from adjuvant chemotherapy. |
Project ref: |
98/36/02 |
Original project title: |
Cost effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy |
Chief Investigator: |
Dr Christopher Williams, Consultant Medical Oncologist,
Cochrane Gynaecological Cancer Review Group, Royal United Hospital
|
Start Date: |
May 2001 |
Date of publication in HTA journal series |
September 2006
|
Cost: |
£75,686 |
MeSH* index primary terms: |
BREAST-NEOPLASMS Q-therapy; HEALTH-CARE-COSTS; PATIENT-SELECTION (* = Medical Subject Headings) |
MeSH* index secondary terms: |
HUMAN; FEMALE; PROGNOSIS; COSTS-AND-COST-ANALYSIS; COST-BENEFIT-ANALYSIS; DECISION-MAKING; QUALITY-OF-LIFE; QUALITY-ADJUSTED-LIFE-YEARS; TUMOR-MARKERS-BIOLOGICAL (* = Medical Subject Headings) |
NRR* number, if applicable: |
N0484087728 (*National Research Register) The National Research Register was a public database of ongoing and recently completed research projects funded by, or of interest to, the United Kingdom's National Health Service (NHS). It is now an archive of projects from early 2000 to September 2007. Search the NRR archive. |
Project Protocol: |
Project protocol not available
|
Printed copies of this title despatched:
|
170 (Figures relate to the previous calendar month) |
URL of this page: |
http://www.hta.ac.uk/1146 |
News feeds